NCT01601769

Brief Summary

Object of the study is the evaluation of the use of a rigid laparoscope for the diagnosis and therapy of lesions of the female genital tract as a substitution or a complementary method to colposcopy with the development of new standards for a tissue sparing therapy Use of existing laparoscopic instruments, which allow a better quality level in the diagnosis and therapy than the current routine. Development of new optics and instruments, which allow a tissue sparing approach Pre and postoperative measurement of the cervical volume, to be sure that the tissue removal is kept to a minimum level Development of qualitaty parameters for the most tissue respecting operations of the uterine cervix Prospective evaluation of the influence of tissue sparing surgery on future pregnancies

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2011

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2011

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

May 14, 2012

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 18, 2012

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

May 18, 2012

Status Verified

May 1, 2012

Enrollment Period

1.3 years

First QC Date

May 14, 2012

Last Update Submit

May 16, 2012

Conditions

Keywords

Cervical preinvasive diseaseColposcopyExocolposcopyLeep

Outcome Measures

Primary Outcomes (4)

  • Cervical volume removed

    Cervical volume removed during the operation is recorded

    İmmediately after surgery

  • İntraoperative Complications

    Complications encountered during the prodecure

    During the intraoperative

  • Short term complications

    Complications within 48 hours after operation

    Within 48 hours after operation

  • Late complications

    Complications occuring after 48 hours

    After 48 hours

Study Arms (2)

Colposcopy

ACTIVE COMPARATOR

a Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter.

Device: Colposcopy

Vitom

EXPERIMENTAL

The VITOM system, consisting of the VITOM scope, xenon light source, HD camera system, AIDA HD documentation system, 1 monitor, and a mechanical support arm (all Karl Storz, Tuttlingen, Germany) is used for video exocolposcopy.

Device: Vitom

Interventions

VitomDEVICE

Patients treated and diagnosed by vitom

Vitom

a Carl Zeiss colposcope with a magnification power from 4x to 20x, with green filter. Patients treated by colposcopy

Colposcopy

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Karnowsky-Index \> 80,
  • years,
  • CIN.

You may not qualify if:

  • Pregnancy,
  • Previous or current cancer,
  • Radio therapy of the pelvis,
  • Serious internistic accompanying diseases,
  • Psychiatric diseases,
  • HIV infection,
  • Drug addiction.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Charité University Hospital

Berlin, State of Berlin, 12200, Germany

Location

MeSH Terms

Interventions

Colposcopy

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Obstetrical and GynecologicalDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeObstetric Surgical ProceduresGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Achim Schneider, MD, MPH

    Charité University Hospital, Berlin, Germany

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

May 14, 2012

First Posted

May 18, 2012

Study Start

April 1, 2011

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

May 18, 2012

Record last verified: 2012-05

Locations